|
Amphotericin B- Liposomal
|
bet | 65/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
Amphotericin B- Liposomal
Revision Date : 16-11-2020
Approved : TC, KOH
Alert
|
Antimicrobial Stewardship Team has listed this drug as Restricted.
Clinicians should liaise with local ID specialists when treating systemic fungal infections.
Available in 4 forms: Amphotericin B -conventional, Amphotericin B - liposomal, Amphotericin B (phospho) lipid complex and Amphotericin B colloidal dispersion also known as Amphotericin B Cholesteryl Sulfate Complex.
Confusion between these products has led to fatal overdose as well as subtherapeutic dosing.1
|
Indication
|
Treatment of invasive fungal infections by susceptible fungi including Candida spp., Aspergillus spp. and Cryptococcus species.2,3 Candida lusitaniae and A. terreus are resistant.
|
Action
|
Fungicidal agent which works by binding with a cytoplasmic membrane ergosterol on the organism’s surface causing cell death by increasing cell membrane permeability.4
|
Drug type
|
Polyene antifungal
|
Trade name
| |
|
| |